Kyorin Holdings Inc
TSE:4569

Watchlist Manager
Kyorin Holdings Inc Logo
Kyorin Holdings Inc
TSE:4569
Watchlist
Price: 1 458 JPY 0.34% Market Closed
Market Cap: 83.8B JPY
Have any thoughts about
Kyorin Holdings Inc?
Write Note

Kyorin Holdings Inc
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kyorin Holdings Inc
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Kyorin Holdings Inc
TSE:4569
Income from Continuing Operations
ÂĄ4.8B
CAGR 3-Years
5%
CAGR 5-Years
-3%
CAGR 10-Years
-8%
Takeda Pharmaceutical Co Ltd
TSE:4502
Income from Continuing Operations
ÂĄ290.2B
CAGR 3-Years
-15%
CAGR 5-Years
28%
CAGR 10-Years
12%
Daiichi Sankyo Co Ltd
TSE:4568
Income from Continuing Operations
ÂĄ250.7B
CAGR 3-Years
42%
CAGR 5-Years
17%
CAGR 10-Years
14%
Otsuka Holdings Co Ltd
TSE:4578
Income from Continuing Operations
ÂĄ155.2B
CAGR 3-Years
1%
CAGR 5-Years
5%
CAGR 10-Years
-1%
Chugai Pharmaceutical Co Ltd
TSE:4519
Income from Continuing Operations
ÂĄ387B
CAGR 3-Years
15%
CAGR 5-Years
23%
CAGR 10-Years
22%
Astellas Pharma Inc
TSE:4503
Income from Continuing Operations
ÂĄ54.7B
CAGR 3-Years
-23%
CAGR 5-Years
-26%
CAGR 10-Years
-7%
No Stocks Found

Kyorin Holdings Inc
Glance View

Market Cap
83.8B JPY
Industry
Pharmaceuticals

KYORIN Holdings, Inc. engages in the development, manufacture and sale of pharmaceutical products through its subsidiaries. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 2,243 full-time employees. The company went IPO on 2006-03-10. The firm operates through two business segments. The Pharmaceuticals segment is engaged in the manufacture, purchase and sales of pharmaceutical products, the evaluation of technologies, the inspection, analysis and negotiation of license affiliations, as well as the research of new drugs and candidate compounds. The company also engages in the purchase and sales of medical promotion tools and packaging materials. The Healthcare segment is engaged in the manufacturing, sales and purchase of environmental sanitation products, general purpose medicines and skin care products.

Intrinsic Value
2 159.31 JPY
Undervaluation 32%
Intrinsic Value
Price

See Also

What is Kyorin Holdings Inc's Income from Continuing Operations?
Income from Continuing Operations
4.8B JPY

Based on the financial report for Sep 30, 2024, Kyorin Holdings Inc's Income from Continuing Operations amounts to 4.8B JPY.

What is Kyorin Holdings Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
-8%

Over the last year, the Income from Continuing Operations growth was -8%. The average annual Income from Continuing Operations growth rates for Kyorin Holdings Inc have been 5% over the past three years , -3% over the past five years , and -8% over the past ten years .

Back to Top